{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:24:50Z","timestamp":1762496690637,"version":"build-2065373602"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071647332"},{"type":"electronic","value":"9781071647349"}],"license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The extracellular matrix (ECM) is a complex network of macromolecules that provides physical structure\u00a0support for tissues and acts as a reservoir for multiple growth factors and signaling mediators modulating the behavior of both cancer and stromal cells within the tumor microenvironment (TME). This key element of the tumor milieu significantly influences various cancer features such as cell differentiation, proliferation, angiogenesis, immune escape, invasion, and metastasis. Therefore, to accurately mimic tumors, it is essential that in vitro models include ECM components. Therefore, to develop 3D biomimetic models for studying cancer, researchers have explored various approaches, including scaffolds made from natural or synthetic polymers and ceramics. However, decellularized ECM derived from patient tumors presents a distinctive model since it preserves the native ECM architecture, biomechanical properties, and molecular composition. Here, we spotlight innovative and advanced protocols to obtain 3D models based on patient-derived decellularized ECM as high-throughput strategies for cancer research, particularly to immunotherapy screening.<\/jats:p>","DOI":"10.1007\/978-1-0716-4734-9_13","type":"book-chapter","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:10:48Z","timestamp":1759273848000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer Patient-Derived Scaffolds as In Vitro Preclinical Models for Immunotherapy Screening"],"prefix":"10.1007","author":[{"given":"Diogo","family":"Est\u00eav\u00e3o","sequence":"first","affiliation":[]},{"given":"Maria J.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"T\u00e2nia B.","family":"Cruz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216\u20131219","journal-title":"Science"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243\u20131253","journal-title":"EMBO Rep"},{"issue":"2","key":"13_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/cancers14020359","volume":"14","author":"\u00c2 Marques-Magalh\u00e3es","year":"2022","unstructured":"Marques-Magalh\u00e3es \u00c2, Cruz T, Costa \u00c2M et al (2022) Decellularized colorectal cancer matrices as bioactive scaffolds for studying tumor-stroma interactions. Cancer 14(2):359","journal-title":"Cancer"},{"issue":"1","key":"13_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11:5120","journal-title":"Nat Commun"},{"issue":"12","key":"13_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2174\/138161209787846711","volume":"15","author":"H Denys","year":"2009","unstructured":"Denys H, Braems G, Lambein K et al (2009) The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment. Curr Pharm Des 15(12):1373\u20131384","journal-title":"Curr Pharm Des"},{"issue":"13","key":"13_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.959834","volume":"30","author":"L Chen","year":"2022","unstructured":"Chen L, Zhang D, Zheng S, Li X, Gao P (2022) Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response. Front Genet 30(13):959834","journal-title":"Front Genet"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.biomaterials.2017.02.004","volume":"124","author":"ML Pinto","year":"2017","unstructured":"Pinto ML, Rios E, Silva AC et al (2017) Decellularized human colorectal cancer matrices polarize macrophages towards an anti-inflammatory phenotype promoting cancer cell invasion via CCL18. Biomaterials 124:211\u2013224","journal-title":"Biomaterials"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes AS, Barros AS, Costa EC et al (2019) 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng 116:206","journal-title":"Biotechnol Bioeng"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd.2016.175","volume":"15","author":"P Horvath","year":"2016","unstructured":"Horvath P et al (2016) Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov 15:751\u2013769","journal-title":"Nat Rev Drug Discov"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"9832","DOI":"10.1038\/s41598-020-66785-1","volume":"10","author":"M Devarasetty","year":"2020","unstructured":"Devarasetty M, Dominijanni A, Herberg S et al (2020) Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro and in vivo. Sci Rep 10:9832","journal-title":"Sci Rep"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1002\/jcp.26403","volume":"233","author":"M Piccoli","year":"2018","unstructured":"Piccoli M, D\u2019Angelo E, Crotti et al (2018) Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research. J Cell Physiol 233:5937\u20135948","journal-title":"J Cell Physiol"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/cas.13843","volume":"110","author":"J Kondo","year":"2019","unstructured":"Kondo J, Ekawa T, Endo H et al (2019) High-throughput screening in colorectal cancer tissue-originated spheroids. Cancer Sci 110:345\u2013355","journal-title":"Cancer Sci"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/ma12081311","volume":"12","author":"T Hoshiba","year":"2019","unstructured":"Hoshiba T (2019) Decellularized extracellular matrix for cancer research. Materials 12:1311","journal-title":"Materials"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.tibtech.2020.04.006","volume":"38","author":"LP Ferreira","year":"2020","unstructured":"Ferreira LP, Gaspar VM, Mano JF (2020) Decellularized extracellular matrix for bioengineering physiomimetic 3D in vitro tumor models. Trends Biotechnol 38:1397\u20131414","journal-title":"Trends Biotechnol"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.actbio.2018.04.044","volume":"74","author":"DA Taylor","year":"2018","unstructured":"Taylor DA, Sampaio LC, Ferdous Z et al (2018) Decellularized matrices in regenerative medicine. Acta Biomater 74:74\u201389","journal-title":"Acta Biomater"},{"issue":"1","key":"13_CR17","first-page":"57","volume":"10","author":"TB Cruz","year":"2021","unstructured":"Cruz TB, Carvalho FA, Matafome PN et al (2021) Mice with type 2 diabetes present significant alterations in their tissue biomechanical properties and histological features. Biomedicine 10(1):57","journal-title":"Biomedicine"}],"container-title":["Methods in Molecular Biology","IMMUNO-model in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4734-9_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:21:41Z","timestamp":1762496501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4734-9_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"ISBN":["9781071647332","9781071647349"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4734-9_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}